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2.0 AÊ Crystal Structure of a Four-Domain Segment
of Human Fibronectin Encompassing the RGD Loop
and Synergy Region
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and Harold P. Erickson³ cellular-matrix molecules, cell-surface receptors, en-
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Johns Hopkins University School of Medicine FN-III domains often occur in pairs or in longer arrays
Baltimore, Maryland 21218 of ten or more repeated domains. Structures of individ-
²Department of Periodontics ual FN-III domains have revealed a conserved b sand-
University of North Carolina wich fold with one b sheet containing four strands and
Chapel Hill, North Carolina 27514 the other sheet containing three strands (DeVos et al.,
³Department of Cell Biology 1992; Leahy et al., 1992; Main et al., 1992; Huber et al.,
Duke University Medical Center 1994). This fold is topologically very similar to that of
Durham, North Carolina 27710 immunoglobulin constant domains (Deisenhofer, 1981),
with notable differences being the lack of a conserved
disulfide bond in FN-III domains and the switching of a
Summary strand between b sheets in FN-III relative to immuno-
globulin domains. Distinctive hydrophobic core packing
We have determined the 2.0 AÊ crystal structure of a and the lack of detectable sequence homology between
fragment of human fibronectin encompassing the sev- immunoglobulin and FN-III domains suggest, however,
enth through the RGD-containing tenth type III repeats that these domains are not evolutionarily related (Main
(FN7±10). The structure reveals an extended rod-like et al., 1992; Leahy et al., 1992).
molecule with a long axis of z140 AÊ and highly variable FN exhibits functional as well as structural modularity.
relationships between adjacent domains. An unusually Sites of interaction with other molecules have been
small rotation between domains 9 and 10 creates a mapped to specific segments of FN corresponding to
distinctive binding site, in which the RGD loop from one or a few modules. In some cases, specific interac-
domain 10 and the ªsynergyº region from domain 9 tions have been further mapped to short stretches of
are on the same face of FN7±10 and thus easily acces- amino acids. Short peptides containing the sequence
sible to a single integrin molecule. The cell-binding Arg±Gly±Asp (RGD) from the tenth type III repeat of FN
RGD loop is well-ordered in this structure and extends will not only block the interaction between FN and inte-
z10 AÊ away from the FN7±10 core. grins but will bind to integrins themselves (Piersch-
bacher and Ruoslahti, 1984; Ruoslahti and Piersch-
Introduction bacher, 1987). RGD sequences active in intermolecular
interactions have subsequently been found in numerous
Fibronectin (FN) is a dimeric glycoprotein composed proteins and mediate a wide variety of cell adhesion
of disulfide-linked subunits with a molecular weight of events (Ruoslahti and Pierschbacher, 1987). The ability
220±250 kDa each. FN is a prominent component of of small RGD-containing peptides to modulate interac-
extracellular matrices and is present at high concentra- tions involved in processes such as thrombosis, inflam-
tions (z300 mg/ml) in plasma. FN interacts with collagen, mation, and tumor metastasis has led to the investiga-
heparin, fibrin, and cell-surface receptors of the integrin tion of RGD peptides and RGD peptide analogs as
family and has been shown to be involved in cell adhe- potential therapeutic agents. While the RGD sequence
sion, cell morphology, thrombosis, cell migration, and
is an important component of interactions between FN
embryonic differentiation (Hynes, 1990). The amino acid
and integrins, additional residues in the ninth type III
sequence of FN revealed it to be a modular protein
domain, the so-called synergy region, of FN have alsocomposed of homologous repeats of three prototypical
been implicated in this interaction (Aota et al., 1991,types of domains known as types I, II, and III (Petersen
1994; Bowditch et al., 1991, 1994). The RGD loop in theet al., 1983; Kornblihht et al., 1985). Electron micro-
tenth type III domain of FN is near the N-terminus ofgraphs of FN show it to be an extended molecule, sug-
this domain (Main et al., 1992; Dickinson et al., 1994),gesting that the repeated sequence motifs represent
and interactions with regions of domain 9 may stabilizeindependently folded modules arranged as ªbeads on
a particular conformation of the RGD loop or provide aa stringº (Engel et al., 1981; Erickson et al., 1981). Struc-
specific context that allows recognition by some inte-ture determinations of isolated domains with homology
grins and not others.to the FN modules have confirmed that the repeats iden-
We undertook an X-ray crystallographic study of atified in the amino acid sequence of FN are indeed inde-
fragment of human FN encompassing the seventhpendently folded domains (Potts and Campbell, 1994).
through the RGD-containing tenth type III repeats (FN7±FN type III (FN-III) repeats are both the largest and the
10) to enable visualization of a complete integrin-bindingmost common of the FN subdomains. Each monomer of
site and provide insight into the structural arrangementFN contains a contiguous array of 15±17 of these z90
of repeated type III domains. We report here the crystalamino acid domains, depending on variations in RNA
structure of FN7±10, refined with data extending to 2.0splicing (Tamkun et al., 1984; Kornblihht et al., 1985).
Domains homologous to FN-III repeats have been found AÊ Bragg spacing.
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Table 1. Anomalous Scattering Factors and MAD Structure Table 2. Data Collection Statistics
Factor Ratios
Number of
l Crystal l(AÊ ) d Spacings (AÊ ) Reflections Complete (%) Rsym kI/sIl
(AÊ ) .9871 .9793 .9790 .9686 f9 f99
SeMet .9871 30±2.6 13402 97.2 5.1 18.6
.9871 0.031 0.036 0.031 0.026 24.22 0.51 SeMet .9793 30±2.6 13237 96.0 5.8 18.5
.9793 0.045 0.028 0.040 29.47 4.23 SeMet .9790 30±2.6 13227 96.0 6.2 18.3
.9791 0.055 0.034 27.65 5.40 SeMet .9686 30±2.6 13228 96.0 5.9 18.0
.9686 0.046 23.26 4.16 Native .9793 30±2.0 28425 95.3 4.3 21.6
The values are (rms (D|F|)/rms (|F|)), in which DF is the Bijvoet differ- Rsym and completeness values were calculated considering Bijvoets
ence at one wavelength (diagonal elements) or the dispersive differ- equivalent. Rsym 5 100 3 ShSi|Ii(h)2kI(h)l|/ShS i Ii(h).
ence between two wavelengths (off-diagonal elements). Centric
data were merged to a single value and are thus not shown. The
Bijvoet difference at l1 may be taken instead as an upper limit of
the noise of the anomalous signals. Also shown are the anomalous density is also ambiguous for residues 1276±1277 and
components of the Se scattering factors as a function of wavelength 1312±1313 in domain 8, and the model in these regions
as determined by MADLSQ (Hendrickson, 1991). is also less certain. Data collection results, refinement
statistics, and stereochemical parameters of the final
FN7±10 model are shown in Tables 1±3.
Results
Overall Structure
The structure of FN7±10 reveals four contiguous FN-IIIStructure Determination
modules in an extended array with a long axis of z140 AÊ .Determination of the FN7±10 crystal structure was aided
A ribbon diagram and Ca backbone trace of the FN7±10by the introduction of potential anomalous scattering
structure are shown in Figure 1 along with a schematicsites by site-directed mutagenesis (Leahy et al., 1994).
diagram of an individual FN-III domain. Table 4 showsMolecular replacement and isomorphous replacement
the relative rotations required to superimpose adjacenttechniques failed to produce a solution of the FN7±10
domains, the angles made by the long axes of adjacentstructure, and the single methionine in domain 8 of the
domains (the ªtiltº angle), and the solvent-accessible368 amino acid FN7±10 is insufficient to allow multiple-
surface area buried between domains for FN7±10. Val-wavelength anomalous diffraction (MAD) phasing tech-
ues for comparable repeated domains from neuroglianniques to be employed with selenomethionyl-substi-
(Huber et al., 1994), CD2 (Jones et al., 1992), and CD4tuted (SeMet) FN7±10 protein (Hendrickson et al., 1990;
(Ryu et al., 1990; Wang et al., 1990) are also shown. AHendrickson, 1991). A hydrophobic core residue in each
near twofold rotation axis relates domain 8 and 9. Thisof domains 7, 9, and 10 was thus mutated to methionine
relationship is similar to those between the domain pairsto provide additional sites for substitution with seleno-
in neuroglian, CD2, and CD4. The rotation between do-methionine. This mutant protein (FN7±10/M) behaved
mains7 and 8 is substantially less (1128), and the rotationidentically to native FN7±10 throughout purification and
between domains 9 and 10 is only 438. The tilt anglescrystallization, although the unit cell dimensions of
between domains 7 and 8 (528) and 8 and 9 (488) areFN7±10/M crystals differed by up to 5% relative to the
comparable to the tilt angles seen between domains innative FN7±10 cell constants.
neuroglian, CD2, and CD4 (468±628), but domains 9 andGrowth of SeMet FN7±10/M crystals that diffracted
10 arearranged inan almost linear fashion (128 tilt angle).well proved difficult, however. Suitable crystals were
The small rotation and tilt angles relating domains 9 andonly obtained when crystallization trials were carried
10 makes this region of FN7±10 approximately cylindri-out in an anaerobic chamber with protein purified in
cal, while the combined tilts and rotations relating do-degassed buffers containing reducing agents (Wu et al.,
mains 7 through 9 result in a slight overall spiral for this1994). Use of freshly purified protein also resulted in
region of FN7±10.improved crystal quality. MAD phasing of SeMet
The interdomain interfaces in FN7±10 are largely com-FN7±10/M crystals grownin these conditions proceeded
posed of residues from loops at the N- and C-terminalsmoothly, and a partially refined FN7±10/M structure
was used to solve the native FN7±10 structure by molec-
ular replacement methods. No significant differences Table 3. Refinement and Stereochemical Statistics
between the FN7±10/M and FN7±10 structures were R value .216 (F . 2s, 6.0±2.0AÊ , 21904 reflections)
found. The refined structure of native FN7±10 is reported .235 (all F, 6.0±2.0AÊ , 24256 reflections)
here. R free .308 (F . 2s, 6.0±2.0AÊ , 1094 reflections)
.330 (all F, 6.0±2.0AÊ , 1225 reflections)The overall map quality for FN7±10 was excellent and
Rms bonds .008 AÊallowed unambiguous placement of all residues in do-
Rms angles 1.68mains 9 and 10 and all but a few loop regions in domains
Average B (AÊ 2) Whole protein 37.7 H2O 30.07 and 8. The average temperature factor for domain 7
Domain 7 48.5 Domain 8 33.7(48.5 AÊ 2) is significantly higher than the average value
Domain 9 30.2 Domain 10 38.2for the other domains (see Table 3), and the electron
A subset of the data (5%) was excluded from refinement and useddensity for loop residues 1153±1159, 1182±1189, and
for the free R value calculation (BruÈ nger, 1992a, 1992b). All data for1204±1205 in this domain is weak. The atomic model in
which |F| . 2s were used in the refinement. R value 5 S||Fo|2|Fc||/these regions is uncertain, although the course of the
S|Fo|.main chain is likely to be generally correct. The electron
Fibronectin Structure
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Figure 1. FN7±10 Structure
(A) A ribbon diagram of the FN7±10 structure is shown. The G±F±C±C9 strands are colored light blue, the A±B±E strands are yellow, and the
RGD loop (residues 1493±1497) is shown in red.
(B) A stereodiagram of a Ca trace of FN7±10 is shown. Side chains at three conserved positions, a tryptophan in the B strand, a leucine in
the E±F loop, and a tyrosine at the beginning of the F strand, are shown in blue, and the side chains of Arg-1493 and Asp-1495 are shown
in red. Every tenth residue is indicated by a solid circle.
(C) A schematic diagram of an FN-III domain is shown with labeled strands. (A) and (B) were made with the program MOLSCRIPT (Kraulis,
1991).
ends of each domain, but the widely varying rotations sequence in the E±F loop makes different interdomain
contacts at each interdomain interface in FN7±10, andrelating adjacent domains result in different interdomain
contacts at each interface. Residues making contacts the conservation of these residues is likely due to their
participation in a conserved turn structure rather thanto a contiguous C-terminal domain occur on the A±Band
E±F loops, while contacts to a contiguous N-terminal their influence on interdomain relationships. With the
exception of the RGD loop in domain 10, superpositiondomain are found on the B±C loop (domain 9) or the
F±G loop (domain 8). Residues making contact at each of the individual FN-III domains in FN7±10 and the X-
ray structure of the isolated tenth type III domain of FNinterface are indicated in Figure 2, and the position of
these loops is shown schematically in Figure 1C. Both (Dickinson et al., 1994) reveals very little variation in the
structure of homologous loops at different interfaces.hydrophobic and hydrophilic contacts are found, and
none of the amino acids in these loops, with the excep- As shown in Table 4, the amount of solvent-accessible
surface area buried at the interface between domainstion of the Pro±Gly sequence in the E±F loop, is highly
conserved in the type III repeats of FN. The Pro±Gly 7 and 8 and 8 and 9 is comparable to that buried at
Cell
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Table 4. Interdomain Rotations, Tilts, and Buried Surface Area
Tilt Rotation Buried Surface
(degrees) (degrees) Area (AÊ 2)
FN(7/8) 52 112 587
FN(8/9) 48 160 527
FN(9/10) 12 43 333
NG(1/2) 62 175 769
CD2(1/2) 60 160 400
CD4(1/2) 46 160 620
The rotation required to superimpose adjacent domains, tilt angles
between the long axes of adjacent domains, and the surface area
buried between these domains is shown for each of the interfaces
in FN7±10 and comparable interfaces in CD2 (Jones et al., 1992),
CD4 (Ryu et al., 1990; Wang et al., 1990), and neuroglian (Huber et
al., 1994). See Experimental Procedures for a description of the tilt
angle.
interdomain interfaces in CD2 and CD4, and somewhat
less than that between the neuroglian domains. The
surface area buried between domains 9 and 10, how-
ever, is notably small by comparison. This interdomain
feature can be seen in Figure 3, where a cleft is visible
separating domain 9 and 10, while no such cleft is seen
between domain 7 and 8 or 8 and 9. The interface be-
tween the neuroglian domains contains a sodium ion
(Huber et al., 1994), but no metal ions were found in
FN7±10.
Individual FN-III Domains
The individual FN-III domains in FN7±10 are very similar
to each other and to the structures of previously solved
FN-III domains. Each domain consists of two b sheets,
one of four strands (G, F, C, and C9) and one of three
strands (A, B, and E), arranged as a b sandwich (see
Figure 1C). An alignment of the amino acid sequences
Figure 3. Orthogonal Views of a Space-Filling Model of FN7±10of the FN-III domains in FN7±10 is shown in Figure 2.
The b sheets are colored as in Figure 1, and the RGD loop (residuesThe positions of the b strands according to thealgorithm
1493±1497) and synergy region (residues 1373±1380) are coloredof Kabsch and Sander (1983) as implemented in the
red and indicated by labels. This figure was made with the program
program PROCHECK (Laskowski et al., 1993) and the QUANTA (Polygen, Incorporated).
fractional solvent accessibility of each amino acid posi-
tion are also indicated in this alignment. Sequence simi-
larity and root-mean-square (rms) Ca differences follow-
ing superposition for each of the domains in FN7±10 as
well as FN-III domains from tenascin (Leahy et al., 1992),
neuroglian (Huber et al., 1994), human growth hormone
receptor (DeVos et al., 1992), and the X-ray (Dickinson
et al., 1994) and nuclear magnetic resonance (NMR)
(Main et al., 1992) structures of the isolated tenth type
Figure 2. Sequence Alignment of the FN-III Domains in FN7±10 III repeat of FN are shown in Table 5. Although the se-
Every tenth residue is indicated with a dot. The b strands as deter- quence similarity for these domains is often at or below
mined by the algorithm of Kabsch andSander (1983) as implemented levels allowing a conclusive determination of structural
in PROCHECK (Laskowski et al., 1993) are enclosed in boxes. The
relatedness (15%±25%; Doolittle, 1986), all of theseRGD loop and the synergy region are shown in bold with white
structures superimpose well. Even at these low levelsletters on a black background. Residues that make contacts with
residues in a C-terminal domain are underlined, and those making of sequence identity, the structural similarity generally
contacts with residues in an N-terminal domain are shown in bold. follows the sequence similarity and shows that the FN-
The residues with atypical features at the interface of domains 9 III domain from tenascin is as closely related to the
and 10, Ser-1417 and Asp-1418, are shown in bold with a stippled FN7±10 domains as they are to themselves, while the
background. Solvent accessibility is indicated for each residue by
neuroglian and human growth hormone receptor do-an open circle if the average fractional solvent accessibility of all
mains are more distantly related to both one anotherresidues at that position is 0.0±0.1, a half-closed circle if 0.1±0.4,
and a closed circle if greater than 0.4. and to the FN domains. The major differences between
Fibronectin Structure
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Table 5. Sequence and Structural Similarity
Rms Ca Differences (AÊ )
FN7 FN8 FN9 FN10 TNfn3 NGfn2 HGHR2
FN7 Ð 0.90 0.88 0.97 1.00 1.21 1.29
FN8 25 Ð 0.45 0.68 0.72 1.32 1.14
FN9 31 34 Ð 0.72 0.77 1.30 1.04
FN10 29 21 26 Ð 0.91 1.44 1.18
TNfn3 22 22 26 27 Ð 1.04 1.10
NGfn2 14 14 13 15 10 Ð 1.35
HGHR2 13 16 14 12 17 6 Ð
Percent Sequence Match
The rms difference in Ca positions of the FN-III domains from FN7±10, the second FN-III domains from human growth hormone receptor
(HGHR2; DeVos et al., 1992) and neuroglian (NGfn2; Huber et al., 1994), and the third FN-III domain from tenascin (TNfn3; Leahy et al., 1992)
are shown in the upper triangle. The 40-residue positions identified as b strand in each of the FN-III domains in FN7±10 (see Figure 2) were
used in the superposition. A superposition of the X-ray (Dickinson et al., 1994) and NMR (Main et al., 1992) structures of the isolated tenth
type III repeat of FN with the same repeat from FN7±10 results in rms differences in the Ca positions of 0.44 and 1.33 AÊ , respectively. The
alignment of Huber et al. (1994) was used for the NGfn2 domain, while the alignment of Leahy et al. (1992) was used for TNfn3 and HGHR2.
The percentage of positions with identical amino acids following sequence alignment is shown in the lower triangle for each pair of domains.
FN-III domains are typically found in the loop regions. The hydrogen bond from the carbonyl oxygen atom of
position 1 to the amide nitrogen atom of position 4 thatThe loop regions of the neuroglian and growth hormone
receptor domains contain insertions of up to several is characteristic of type II9 turns is not present in this
RGD loop (d(O1493 2 N1496) 5 4.14 AÊ ). The absenceamino acids, and the only loop of constant length in all
of the FN7±10 domains is the E±F loop. of this hydrogen bond in the FN7±10 RGD loop contrasts
with the RGD loop in the third FN-III domain from tenas-Smaller structural elements are also highly conserved
among the FN-III domains or subsets of these domains cin, in which this hydrogen bond is made (Leahy et al.,
1992).and thus likely to contribute to optimal functioning of
these domains. All of the domains listed in Table 5 have
a b bulge of the ªwideº type (Chan et al., 1993) at the Discussion
beginning of the A strand immediately following a highly
conserved proline residue. This conserved prolyl side We have determined thehigh resolution crystal structure
chain is buried and contacts a conserved tryptophan of a fragment of human FN encompassing the seventh
side chain from strand B. With the possible exception through the RGD-containing tenth type III repeats. This
of domain 7, in which this region is not well-ordered, A structure reveals an extended RGD loop and the relation
strands in the FN and tenascin domains also end with of this loop to the synergy region. In addition, apparently
a conserved wide-type b bulge immediately prior to a subtle differences in amino acid sequence result in sur-
hairpin turn connecting the A and B strands. Also note- prisingly different rotations and tilts relating adjacent
worthy is a conserved serine residue in strand G whose FN-III domains.
side chain is buried and makes hydrogen bonds to the
carbonyl oxygen atom of the succeeding residue and Interdomain Relationships
the amide nitrogen atom of a residue from the adjacent As individual FN-III domains share a highly conserved
F strand. As noted by Huber et al. (1994), this structure framework structure (DeVos et al., 1992; Leahy et al.,
can be thought of as a turn of nonidealpolyproline II helix 1992; Main et al., 1992; Huber et al., 1994), the key to a
and is extended in theneuroglian domain structures.The molecular understanding of many of the properties of
side chain of a conserved threonine residue found at repeated arrays of FN-III domains will be understanding
the C-terminus of the FN and tenascin domains is also interdomain relationships. Several groups have postu-
buried and makes hydrogen bonds to the main chain of lated a pseudotwofold relationship between adjacent
residues in the E±F connection that may serve to stabi- domains (Leahy et al., 1992; Bowditch et al., 1994), and
lize this structure at the C-terminal domain interface. such a relationship was observed in a structure of tan-
dem repeats of FN-III domains from neuroglian (Huber
et al., 1994). As seen in Table 4, however, of the threeRGD Structure
The RGD sequence in domain 10 that has been shown interdomain interfaces in FN7±10, only that of domains
8 and 9 approximates a twofold.to bean important component of cell adhesion reactions
is well-ordered in this crystal. The RGD is found on an Examination of each interdomain interface in FN7±10
reveals no general rules relating the orientations be-extended b hairpin±like loop that makes no contacts
with other regions of the FN molecule (see Figures 1 tween adjacent domains, but the interface between do-
mains 9 and 10 is unmistakably distinctive. The relativeand 3), although it does participate in a crystal lattice
contact as shown in Figure 4. The main-chain torsion rotation, amount of buried surface area, and tilt angle
are notably smaller than all other known FN-III interfacesangles of Gly-1494 and Asp-1495 ([808, 21648] and
[2758, 2248], respectively) suggest that the loop can be (see Table 4). Comparison of main-chain torsion angles
at interdomain boundaries in FN7±10 reveals that thethought of as a distorted type II9 turn (Richardson, 1981).
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principal source of the relatively small rotation relating
domains 9 and 10 is an atypical c torsion angle at the
N-terminus of domain 10. The main-chain torsion angles
within three residues of interdomain boundaries in
FN7±10 are uniformly in the b region of a Ramachandran
plot with the exception of Asp-1418 at the 9/10 interface
with (w, c) values of (-978, 98). This c value differs by 1228
and 1438 from the c value at the homologous positions at
the 7/8 and 8/9 interfaces, respectively, and results in
a shift of approximately this order of magnitude in the
rotation relating domains 9 and 10. The large shift in
the relative orientation of domain 9 and 10 results in the
side chain of the residue preceding Asp-1418 (Ser-1417)
becoming exposed to solvent. At the 7/8 and 8/9 inter-
faces, the residues in positions homologous to Ser-1417
are hydrophobic and completely buried at the interdo-
main interface. With the exceptions of the first and tenth
type III repeats of FN, all residues in FN at positions
homologous to Ser-1417 are hydrophobic, suggesting
that the interdomain orientations in FN are likely to be
more similar to the relative orientations seen between
domains 7/8 and 8/9 and bury the side chain at this
position at the interdomain interface.
The interface between domains 7 and 8 also pos-
sesses a unique feature, an insertion of two amino acids
in the A±B loop of domain 7. This insertion undoubtedly
influences the relative orientation of domains 7 and 8,
but the A±B loop in domain 7 is not well-ordered in
the FN7±10 structure and the specific effects of this
insertion are difficult to evaluate. The EIIIB FN-III domain
is inserted between domains 7 and 8 in splice variants
of FN, and the atypical A±B loop of domain 7 may also
influence the relationship of domain 7 with the EIIIB
domain. The interface between domains 8 and 9 thus
appears to be the best template for modeling other do-
main relationships in FN, but the demonstrated variabil-
ity of interdomain relationships in FN7±10and the appar-
ent ability of small sequence differences to effect
significant structural differences suggest that more
structural information is needed to assess this hy-
pothesis.
The unusually small rotation relating domains 9 and
10 places the RGD loop from domain 10 and the synergy
region of domain 9 on the same surface of the FN mole-
cule (see Figure 3). Although the RGD loop and the
synergy region are separated by 30±40 AÊ , a single inte-
grin molecule could span this dimension and interact
simultaneously with both the RGD loop and the synergy
region. A scale model of an integrin interacting with an
FN molecule is shown in Figure 5. The small rotation
relating domains 9 and 10 is no doubt required for a
maximal interaction between FN and an integrin, and
the uniqueness of this relationship almost certainly adds
additional specificity to this interaction by providing a
Figure 4. The RGD Loop
(A) A ball-and-stick model of the RGD loop is shown superimposed
with a simulated annealing omit map (Hodel et al., 1992) contoured
at 0.8s.
(B) A ball-and-stick model of the RGD loop and the region of a
symmetry-related molecule that it contacts are shown. This figure
was made with the program O (Jones and Kjeldgaard, 1991).
Fibronectin Structure
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Figure 5. Scale Model of FN/Integrin Inter-
action
A Ca model of a straightened FN molecule is
shown with a scaled electron-micrographic
imageof the aIIbb3 integrin (Carrell et al., 1985).
The NMR structure of type I domains 4 and
5 (Williams et al., 1994) was used to generate
the type I domains, and the NMR structure of
a domain with homology to type II FN repeats
(Constantine et al., 1992) was used to gener-
ate the type II domains. The FN7±10 structure
is used to represent itself, while the other type
III domains are modeled with domains 8 and 9 of FN7±10 and their relative orientation. The type I domains are colored dark blue, the type II
domains are colored red, and the type III domains are colored green with the exception of domains 7 through 10 that are colored light blue.
The cell-binding RGD loop is colored red. Ligand-binding sites that have been mapped to specific segments of FN are labeled (Hynes, 1990),
and sites of inserted domains in splice variants of FN are indicated by the labels A, B, and V. The two cysteines involved in interdomain
dimerization are indicated schematically at the C-terminus. The juxtaposition of scaled integrin and FN molecules emphasizes the very large
size of the integrin relative to the FN-III domains and illustrates that a single integrin can easily span the RGD and synergy regions.
constellation of contacts not easily mimicked or repro- conformation in high salt (Erickson and Carrell, 1983;
Rocco et al., 1983; Lai et al., 1993). Even in the extendedduced by other pairs of FN-III domains.
The relative rigidity or flexibility of repeated FN-III do- conformation, a number of bend points are seen in elec-
tron micrographs (Engel et al., 1981; Erickson et al.,mains is also likely to be an important component of FN
structure. While a crystal structure generally gives little 1981). Electron micrographs of FN in the compact con-
formation (Erickson and Carrell, 1983) showed strandsglobal information about the dynamic properties of a
molecule, considerable overall rigidity of FN7±10 seems folded back upon themselves, apparently owing to an
increased number of bends or increased bend anglesindicated by its ability to form well-ordered crystals.
Comparison of the amount of surface area buried at (or both). It was unclear whether bending was possible
between every pair of FN-III domains, or was limited tointerdomain interfaces in FN7±10 and similar tethered
domains also suggests relatively rigid domain relation- a fewspecific hinge regions. The present study suggests
that a small number of hinges, with weaker interdomainships for at least the 7/8 and 8/9 interfaces (see Table
4). While the neuroglian domains contain a sodium ion interfaces like that seen between domains 9 and 10,
might be dispersed between relatively rigid segments.at their interface and are thus less appropriate for com-
parison, the amount of surface area buried between Bending at these few hinges could account for the fold-
ing of FN into the compact conformation.domains in CD4 and CD2 is comparable to or less than
that buried at the 7/8 and 8/9 interfaces in FN7±10. The Litvinovich and Ingham (1995) proposed, on the basis
of calorimetric measurements, that there may be a directD1/D2 interface of CD4 domains is thought to be quite
rigid, as the same interdomain relationship has been interaction between domains 7 and 9. Direct contact
between these domains would require 908 bends at bothobserved in multiple crystal forms (Ryu et al., 1994). The
CD2 domains contain an insertion of four amino acids the 7/8 and 8/9 interfaces. These interfaces appear to
be the most rigid interfaces in FN7±10, however, andat their interdomain boundary relative to CD4 D1/D2
and bury less surface area, and two independent CD2 this large deviation from the crystal structure seems
unlikely.molecules in the crystallographic asymmetric unit dif-
fered by 78 in the relativeorientation of adjacent domains
(Jones et al., 1992). CD2 is thus thought to be more RGD Structure
The cell-binding RGD loop of domain 10 is well-orderedflexible and sustain flexion of 78 or greater in solution.
The amount of surface area buried between domains in the FN7±10 structure and is shown in Figure 4A. As
can be seen in Figures 1 and 3, the RGD loop extends9 and 10 in FN7±10 (330 AÊ 2) is lower than that buried
between the CD2 domains and is significantly lower than z10 AÊ away from the body of the FN7±10 molecule with
no close contacts to any other part of FN7±10. Thethat buried between all other known FN-III domain pairs.
While the 9/10 interface is thus likely to be more flexible visualization of this extended and isolated loop provides
a satisfying context for understanding how small RGD-than even the CD2 domains, the juxtaposition of the
RGD loop and the synergy region in the FN7±10structure containing peptides are able to block interactions be-
tween FN and cells. The RGD loop in FN7±10 is stabilizedsuggests that the observed orientation must be close
to the orientation recognized by integrins. The RGD loop by a crystal lattice contact as shown in Figure 4B. Since
the RGD loop is disordered in the structure of isolatedand synergy region are recognized by at least two differ-
ent integrins (Aota et al., 1994; Bowditch et al., 1994), domain 10 from FN as determined by both NMR (Main
et al., 1992) and X-ray crystallography (Dickinson et al.,and some flexibility at the 9/10 interface may be impor-
tant in maximizing these interactions. Regardless of the 1994), the RGD loop structure seen here most likely
represents a low energy conformer of an otherwise flexi-inherent rigidity or flexibility of the 9/10 domain pair, the
smaller interface between these domains suggests that ble loop (Kossiakoff et al., 1992).
Many features of this RGD structure are likely to bethis junction will deform more easily in response to
stress. FN undergoes a dramatic change from a com- relevant to its cell-binding function. The FN7±10 RGD
has the characteristics of a slightly deformed type II9 bpact conformation at low ionic strength to an extended
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hairpin turn (Richardson, 1981). Type II9 turns typically seen in any of the other FN-III domains in FN or tenascin
and appears to be an adaptation necessary to projectrequire glycine in the second position as the canonical
the RGD for optimal interaction with an integrin.(w, c) values for this position (60, 2120) are energetically
unfavorable for nonglycine amino acids. The RGD gly-
Experimental Procedurescine may thus be in part conserved to allow an appro-
priate turn at this position. In addition to the present
Expression and Purificationstudy, three X-ray structures have been reported for
The region of a human FN cDNA (Kornblihht et al., 1985) encodingproteins containing RGD sequences that are active in
the seventh through the tenth type III repeats (Pro-1142 to Thr-1509)
cell adhesion. In all cases, the RGD forms a type II9 b was amplified by PCR, subcloned into the pET11b expression vector
turn with overall structure similar to that observed in (Studier et al., 1990), and expressed and purified as described pre-
viously (Aukhil et al., 1993; Leahy et al., 1994). The DNA sequenceFN7±10. One is an FN-III domain from tenascin that has
of this fragment was determined and found to contain mutationsan RGD sequence in its F±G loop in a position homolo-
resulting in amino acid changes at two positions. These mutationsgous to the RGD in domain 10 of FN (Leahy et al., 1992).
were corrected to the native sequence by site-directed mutagenesisSecond is the leech disintegrin decorsin that has an (Kunkel et al., 1987).
RGD loop projecting from a hirudin-like structure (Krezel To aid in MAD phasing via selenomethionyl-substituted (SeMet)
et al., 1994). Third is an artificial protein in which the protein (Hendrickson et al., 1990), an additional FN7±10 clone was
constructed in which Leu-1160, Ile-1333, and Leu-1433 were re-sequence CRGDSC was inserted into lysozyme (Ya-
placed with methionine. Both the native FN7±10 and the FN7±10mada et al., 1995). The four described RGD loops inter-
containing three additional methionines (FN7±10/M) were found inact with at least three different integrins. The tenascin
the soluble fraction of bacterial lysates and behaved similarly
domain and the lysozyme protein interact with aVb3, de- through succeeding purification steps. Purification consisted of an
corsin interacts with aIIbb3, and FN7±10 interacts with initial precipitation with 40% saturated (NH4)2SO4 followed by chro-
a5b1, aIIbb3, and perhaps aVb3. The higher antiadhesive matography on Mono Q and then Mono S ion-exchange columns.
SeMet protein was prepared as described previously (Leahy et al.,activities of cyclic RGD peptides (Pierschbacher and
1994), with the exception that degassed buffers were used duringRuoslahti, 1987) imply that a turn or loop structure is an
all purification steps.important component of integrin recognition, and the
presence of type II9 turns in multiple RGD loops inter- Crystallization
acting with multiple integrins suggests that this particu- Crystals were grown in hanging drops by the method of vapor diffu-
lar loop structure represents a general integrin-binding sion. All forms of FN7±10 crystallized in similar conditions. Purified
protein was dialyzed into dH2O (plus 2 mM b-mercaptoethanol in theconformation.
case of SeMet protein) and concentrated to z7.5 mg/ml. ReservoirThe NMR structures of several snake venom toxins
buffer consisted of 5%±10% PEG 3350, 20 mM Li2SO4, and 10 mMwith active RGD loops have also been determined (Adler
sodium cacodylate (pH 5.8). We mixed 1 ml of a 1:1 dilution of
et al., 1991; Saudek et al., 1991). In each case, the RGD reservoir buffer with dH2O with 1 ml of protein solution and equili-
sequence appeared on an extended flexible loop, and brated it over undiluted reservoir buffer. Crystals grew in 1±3 days
the precise conformation of the RGD was uncertain. to a typical size of 0.15 mm 3 0.15 mm 3 0.6 mm. Growth of
diffraction quality SeMet crystals required the use of degassed buf-The anti-integrin activity of these toxins is consistent,
fers throughout purification, the presence of reducing agents, andhowever, with a type II9±like turn confomation being
the use of an anaerobic chamber during setup of the hanging drops
easily accessible for these loops. The structures of many (Wu et al., 1994). FN7±10 and FN7±10/M crystallize in space group
small RGD-containing peptides and peptide analogs P21 with cell constants of a 5 64.05, b 5 60.67, c 5 58.44 AÊ , and
with the ability to block or mimic RGD-mediated interac- b 5 103.08 and a 5 67.67, b 5 57.96, c 5 58.33 AÊ , and b 5 106.38,
respectively.tions have also been investigated (Gurrath et al., 1992;
Craig et al., 1995). While many of these compounds
Data Collection and Processingadopt type II9 turn±like structures, other conformations
All diffraction data were collected on Fuji phosphorimaging plates
are also encountered. Investigation of RGD analog at beamline X4A of the National Synchrotron Light Source at Brook-
structures and comparison with the RGD structures haven National Laboratory from crystals soaked for at least 15 min
found in proteins will no doubt further define general in reservoir buffer containing 20% (w/v) PEG 3350 and 10% (w/v)
ethylene glycol and flash-frozen in a gaseous nitrogen stream atfeatures of active RGD conformation and provide insight
21808C. Native data were collected from a single FN7±10 crystal atinto any differences in preferred RGD conformation that
wavelength .9793 AÊ , and MAD data were collected at four wave-may exist between different integrins.
lengths from a single SeMet FN7±10/M crystal. 2.58 oscillations at
A striking feature of the RGD loop of FN7±10 is the w and w plus 1808 were collected with no overlap for each oscillation
distance it projects from the core of the molecule. The range at each wavelength. All diffraction images were processed
with the program DENZO and scaled with the program SCALEPACKhomologous RGD loop in tenascin mediates strong ad-
(Otwinowski, 1993). <I1> and <I2> were used for MAD phase deter-hesion of endothelial cells when it is exposed as the
mination, and partially recorded reflections were used in all cases.N-terminal domain, but adhesion was substantially
Diffraction data from different wavelengths were scaled with the
weakened when the domain was incorporated into a program WVLSCL, and FAs and optimal f9 and f99 were calculated
larger, multidomain segment (Joshi et al., 1993). The with MADLSQ (Hendrickson, 1991).
accessibility of the tenascin RGD loop is apparently di-
Structure Determinationminished when another domain is attached at the N-
Four selenium sites were deduced from inspection of FA Pattersonterminus, making the RGD less active in adhesion. The
and difference Fourier maps and confirmed with the programRGD loop in FN avoids being obscured by the insertion
HEAVY. Phase determinations were made with the program
of two amino acids on each side of the RGD loop, ex- MLPHARE. The Ca backbone of an FN-III domain from tenascin
tending the RGD an additional z7 AÊ from the core of (Leahy et al., 1992) was easily placed at four positions in the resulting
MAD-phased electron density maps, and these positions lined upthe FN molecule. This extension of the RGD loop is not
Fibronectin Structure
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N-terminal to C-terminal as expected. Following placement of the search strategy based on Patterson correlation refinement. Acta
Crystallogr. A46, 46±57.tenascin models, the four selenium sites were found to correspond
precisely with the positions of expected methionine residues. A BruÈ nger, A.T. (1992a). The free R value: a novel statistical quantity for
complete atomic model for Pro-1142 to Thr-1509 was then built into assessing the accuracy of crystal structures. Nature 355, 472±474.
a 2.6 AÊ MAD-phased electron density map with the program O
BruÈ nger, A.T. (1992b). XPLOR, Version 3.1: A System for X-Ray(Jones and Kjeldgaard, 1991). Following simulated annealing and
Crystallography and NMR (New Haven, Connecticut: Department ofPowell refinement with the program X-PLOR (BruÈnger, 1992a,
Molecular Biophysics and Biochemistry, Yale University).1992b), this model had an R value (S||Fo| 2 |Fc||/S|Fo|) of .277 for all
data in the resolution range 8.0±2.1 AÊ for which F > 2s from the Carrell, N.A., Fitzgerald, L.A., Steiner, B., Erickson, H.P., and Phillips,
SeMet data collected at .9717 AÊ . Molecular replacement with PC D.R. (1985). Structure of human platelet membrane glycoproteins
refinement (BruÈ nger, 1990) was then used to place this model into IIb and IIIa as determined by electron microscopy. J. Biol. Chem.
the FN7±10 unit cell, and all subsequent refinement steps were 260, 1743±1749.
performed with diffraction data from native crystals. Several rounds Chan, A.W.E., Hutchinson, E.G., Harris, D., and Thornton, J.M.
of simulated annealing and/or Powell minimization alternated with (1993). Identification, classification, and analysis of b-bulges in pro-
model building have produced the current model of FN7±10. This teins. Protein Sci. 2, 1574±1590.
model consists of residues Pro-1142 to Thr-1509 (2820 nonhydrogen
Constantine, K.L., Madrid, M., Banyai, L., Trexler, M., Patthy, L.,atoms) and 259 water molecules. Tilt angles (Table 4) represent the
and Llinas, M. (1992). Refined solution structure and ligand-bindingacute angle made by the long axes of adjacent domains. A good
properties of PDC-109 domain b: a collagen-binding type II domain.approximation of the long axis of each FN-III domain was found by
J. Mol. Biol. 223, 281±298.connecting the Ca positions of residues at the midpoints of the B±C
(1170, 1262, 1353, and 1443) and E±F loops (1208, 1299, 1389, and Craig, W.S., Cheng, S., Mullen, D.G., Blevitt, J., and Pierschbacher,
1479). Refinement statistics and stereochemical parameters for this M.. (1995). Concept and progress in the development of RGD-con-
model are shown in Table 3. taining peptide pharmaceuticals. Biopolymers 37, 157±175.
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